 - Prior multiple myeloma, lymphoproliferative disease and amyloidosis. M-protein 30 gL or involved:uninvolved serum FLC ratio 100. Individuals with prior history of MGUS will be offered to be randomized into either moderate or intensive clinical follow-up arms 2 or 3. 